Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/27/2025

Anemia's Role in Lower Extremity Edema

Mechanism and Prevalence

  • Anemia increases heart rate and cardiac output, placing additional stress on the heart, which can lead to fluid accumulation in patients with heart failure 1
  • The European Society of Cardiology recommends considering anemia as a contributing factor to heart failure, as it worsens cardiac function through multiple pathways 1
  • Anemia is present in approximately one-third of patients with congestive heart failure, according to the American College of Cardiology 2, 3
  • The American Heart Association notes that anemic patients with heart failure have significantly higher all-cause mortality, hospitalization, and CHF hospitalization compared to non-anemic patients 4

Pathophysiologic Contributors

  • Iron deficiency is present in 50-70% of ambulatory or hospitalized heart failure patients, often due to inflammation-induced hepcidin elevation blocking iron absorption and release, as reported by the American Society of Hematology 4
  • Inflammation suppresses erythropoietin production and erythropoiesis while increasing hepcidin synthesis, contributing to anemia in patients with chronic conditions 4
  • Hemodilution is common in heart failure, contributing to apparent anemia, according to the American College of Physicians 2, 3

Clinical Guidelines and Recommendations

  • The American College of Physicians recommends against routine use of erythropoiesis-stimulating agents in mild to moderate anemia with heart failure due to lack of mortality benefit 2, 3
  • The European Society of Cardiology suggests that correcting anemia with erythropoietin and intravenous iron may improve cardiac function, reduce hospitalizations, decrease diuretic requirements, and stabilize or improve renal function 5
  • The American College of Cardiology recommends checking hemoglobin in all patients with edema and underlying heart failure, kidney disease, or liver disease 5